Literature DB >> 9554625

Breathing reserve at the lactate threshold to differentiate a pulmonary mechanical from cardiovascular limit to exercise.

B D Medoff1, D A Oelberg, D J Kanarek, D M Systrom.   

Abstract

STUDY
OBJECTIVES: Criteria used to define the respective roles of pulmonary mechanics and cardiovascular disease in limiting exercise performance are usually obtained at peak exercise, but are dependent on maximal patient effort. To differentiate heart from lung disease during a less effort-dependent domain of exercise, the predictive value of the breathing reserve index (BRI=minute ventilation [VE]/maximal voluntary ventilation [MVV]) at the lactate threshold (LT) was evaluated.
DESIGN: Thirty-two patients with COPD and a pulmonary mechanical limit (PML) to exercise defined by classic criteria at maximum oxygen uptake (VO2max) were compared with 29 patients with a cardiovascular limit (CVL) and 12 normal control subjects. Expired gases and VE were measured breath by breath using a commercially available metabolic cart (Model 2001; MedGraphics Corp; St. Paul, Minn). Arterial blood gases, pH, and lactate were sampled each minute during exercise, and cardiac output (Q) was measured by first-pass radionuclide ventriculography (System 77; Baird Corp; Bedford, Mass) at rest and peak exercise.
RESULTS: For all patients, the BRI at lactate threshold (BRILT) correlated with the BRI at VO2max (BRIMAX) (r=0.85, p<0.0001). The BRILT was higher for PML (0.73+/-0.03, mean+/-SEM) vs CVL (0.27+/-0.02, p<0.0001), and vs control subjects (0.24+/-0.03, p<0.0001). A BRILT > or = 0.42 predicted a PML at maximum exercise, with a sensitivity of 96.9%, a specificity of 95.1%, a positive predictive value of 93.9%, and a negative predictive value of 97.5%.
CONCLUSIONS: The BRILT, a variable measured during the submaximal realm of exercise, can distinguish a PML from CVL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554625     DOI: 10.1378/chest.113.4.913

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing.

Authors:  William M Oldham; Gregory D Lewis; Alexander R Opotowsky; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 2.  The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease.

Authors:  Scott J Butcher; Richard L Jones
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

3.  Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity.

Authors:  Alexander R Opotowsky; Michael J Landzberg; Michael G Earing; Fred M Wu; John K Triedman; Alicia Casey; Dawn A Ericson; David Systrom; Stephen M Paridon; Jonathan Rhodes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-02       Impact factor: 4.733

Review 4.  Maximising the clinical use of exercise gaseous exchange testing in children with repaired cyanotic congenital heart defects: the development of an appropriate test strategy.

Authors:  A McManus; M Leung
Journal:  Sports Med       Date:  2000-04       Impact factor: 11.136

5.  Exercise-induced pulmonary arterial hypertension.

Authors:  James J Tolle; Aaron B Waxman; Teresa L Van Horn; Paul P Pappagianopoulos; David M Systrom
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

6.  Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.

Authors:  Rudolf K F Oliveira; Aaron B Waxman; Paul J Hoover; Paul F Dellaripa; David M Systrom
Journal:  Chest       Date:  2020-03-12       Impact factor: 9.410

7.  Invasive Hemodynamic and Metabolic Evaluation of HFpEF.

Authors:  J Emanuel Finet; Erik H Van Iterson; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-26

8.  Cardiopulmonary Exercise Testing in Patients Following Massive and Submassive Pulmonary Embolism.

Authors:  Mazen S Albaghdadi; David M Dudzinski; Nicholas Giordano; Christopher Kabrhel; Brian Ghoshhajra; Michael R Jaff; Ido Weinberg; Aaron Baggish
Journal:  J Am Heart Assoc       Date:  2018-03-03       Impact factor: 5.501

9.  Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease.

Authors:  Jean Pastré; Anne Prévotat; Catherine Tardif; Carole Langlois; Alain Duhamel; Benoit Wallaert
Journal:  BMC Pulm Med       Date:  2014-04-30       Impact factor: 3.317

10.  Oxygen Uptake Efficiency Slope and Breathing Reserve, Not Anaerobic Threshold, Discriminate Between Patients With Cardiovascular Disease Over Chronic Obstructive Pulmonary Disease.

Authors:  Anthony Barron; Darrel P Francis; Jamil Mayet; Ralf Ewert; Anne Obst; Mark Mason; Sarah Elkin; Alun D Hughes; Roland Wensel
Journal:  JACC Heart Fail       Date:  2016-02-10       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.